Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Nov:156:110684.
doi: 10.1016/j.mehy.2021.110684. Epub 2021 Sep 20.

Is digital necrosis in COVID-19 caused by neutrophil extracellular traps: Potential therapeutic strategies

Marian Simka  1
Affiliations
Review

Is digital necrosis in COVID-19 caused by neutrophil extracellular traps: Potential therapeutic strategies

Marian Simka. Med Hypotheses. 2021 Nov.

Abstract

Some of the COVID-19 patients present with ischemic lesions of their finger and toes. Standard anticoagulant therapy is usually unsuccessful for the treatment of this unique presentation of COVID-19. In this review current evidence is presented, which supports the hypothesis that these necrotic lesions are primarily related to the formation of neutrophil extracellular traps is blood vessels. Also, currently available and potential pharmacological methods of the management of this unique thrombotic complication are discussed. Drugs that possibly could be used in COVID-19 patients suffering from acute ischemia of distal parts of the extremities particularly comprise DNase I and DNase1L3, which could directly dissolve these extracellular webs that are mostly composed of DNA. However, at the moment, none of these enzymes are registered for an intravascular administration in humans. Lactoferrin and dipyridamole are other pharmaceutical agents that could potentially be used for the treatment of neutrophil extracellular traps-evoked digital ischemia. These agents exhibit prophylactic activity against excessive formation of these extracellular structures. Such an experimental treatment should probably be accompanied by standard antithrombotic management with heparin. Open-label and then randomized trials are needed to confirm feasibility, safety and efficacy of the above-suggested management of critically ill COVID-19 patients.

Keywords: COVID-19; DNase; Digital ischemia; Neutrophil extracellular traps.

PubMed Disclaimer

Conflict of interest statement

There is no conflict of interest associated with the paper: “Is digital necrosis in COVID-19 caused by neutrophil extracellular traps: potential therapeutic strategies”.

Figures

Fig. 1
Fig. 1
Potential pharmaceutical strategies targeting NETs in COVID-19 patients.
See this image and copyright information in PMC

References

    1. Novara E., Molinaro E., Benedetti I., et al. Severe acute dried gangrene in COVID-19 infection: a case report. Eur Rev Med Pharmacol Sci. 2020;24:5769–5771. - PubMed
    1. Shih L, Ferry AM, Gravina PR, et al. Acute digital necrosis in a patient with Raynaud’s phenomenon and COVID-19 infection. Am Surg 2020; doi: 10.1177/0003134820979788. - PubMed
    1. Wang JS, Pasieka HB, Petronic-Rosic V, et al. Digital gangrene as a sign of catastrophic coronavirus disease 2019-related microangiopathy. Plast Reconstr Surg Glob Open 2020;8:e3025. - PMC - PubMed
    1. Del Giudice P., Boudoumi D., Le Guen B., Reverte M., Gutnecht J., Lacour J.P., et al. Catastrophic acute bilateral lower limbs necrosis associated with COVID-19 as a likely consequence of both vasculitis and coagulopathy. J Eur Acad Dermatol Venereol. 2020;34(11) doi: 10.1111/jdv.v34.1110.1111/jdv.16763. - DOI - PMC - PubMed
    1. Schultz K., Wolf J.M. Digital ischemia in COVID-19 patients: case report. J Hand Surg Am. 2020;45(6):518–522. - PMC - PubMed